LanteRNA Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

LanteRNA General Information

Description

Developer of fluorescence labeling methodologies and concepts designed to help biotechnological research and discoveries. The company's technology uses small and natural fluorophores in microscopy and also provides consulting services in the field of fluorescence-based labeling, enabling biotechnology researchers to use stand-alone fluorescent markers in biochemical and biological research and development.

Contact Information

Website
www.lanterna.tech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Chalmers Ventures AB
  • Vera Sandbergs alle 8
  • 412 96 Gothenburg
  • Sweden
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • Care of Chalmers Ventures AB
  • Vera Sandbergs alle 8
  • 412 96 Gothenburg
  • Sweden

LanteRNA Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LanteRNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Jul-2026 Completed Generating Revenue
4. Seed Round 06-May-2024 Completed Startup
3. Grant 01-Oct-2022 Completed Startup
2. Seed Round 29-Jun-2022 $29.7K $35.4K Completed Startup
1. Accelerator/Incubator 19-Oct-2021 $5.74K $5.74K Completed Startup
To view LanteRNA’s complete valuation and funding history, request access »

LanteRNA Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view LanteRNA’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

LanteRNA Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

LanteRNA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3216383-A1 Fluorescent nucleoside phosphates Pending 12-Apr-2021
EP-4323373-A1 Fluorescent nucleoside phosphates Pending 12-Apr-2021
JP-2024513957-A Fluorescent nucleoside phosphates Pending 12-Apr-2021
US-20240209016-A1 Fluorescent nucleoside phosphates Pending 12-Apr-2021
WO-2022218943-A1 Fluorescent nucleoside phosphates Inactive 12-Apr-2021 C07H19/04
To view LanteRNA’s complete patent history, request access »

LanteRNA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LanteRNA Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Almi Invest Venture Capital Minority
Vinnova Government
Life Science Invest Angel Group Minority
To view LanteRNA’s complete investors history, request access »

Ready to get started?

Request a free trial

LanteRNA FAQs

  • When was LanteRNA founded?

    LanteRNA was founded in 2021.

  • Where is LanteRNA headquartered?

    LanteRNA is headquartered in Gothenburg, Sweden.

  • What is the size of LanteRNA?

    LanteRNA has 6 total employees.

  • What industry is LanteRNA in?

    LanteRNA’s primary industry is Biotechnology.

  • Is LanteRNA a private or public company?

    LanteRNA is a Private company.

  • What is LanteRNA’s current revenue?

    The current revenue for LanteRNA is .

  • How much funding has LanteRNA raised over time?

    LanteRNA has raised $552K.

  • Who are LanteRNA’s investors?

    Almi Invest, Vinnova, and Life Science Invest have invested in LanteRNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process